false
OasisLMS
Login
Hamburger Menu
Catalog
CMR in Ischaemic Heart Disease: From Viability and ...
CMR in Ischaemic Heart Disease: From Viability and Infarct Characterisation to Clinical Decision-Making in Chronic Coronary Disease
Create Account
Availability
On-Demand
Cost
$0.00
Credit Offered
1 General Hour Credit
CMR in Ischaemic Heart Disease: From Viability and Infarct Characterisation to Clinical Decision-Making in Chronic Coronary Disease
CMR in Ischaemic Heart Disease: From Viability and Infarct Characterisation to Clinical Decision-Making in Chronic Coronary Disease - Educational Grant Provided by Bayer
Date: November 5, 2026
Case-based webinar explores how CMR informs key clinical decisions across the ischemic spectrum, integrating current AHA/ACC guidelines for chronic coronary disease (2023), acute coronary syndromes (2025), and chest pain evaluation (2021). Using real-world scenarios, we'll demonstrate stress perfusion CMR as a gatekeeper to the cath lab and its positioning within the appropriate use framework; viability assessment showing how transmural extent of LGE combined with quantitative scar burden may inform revascularization decisions; and post-MI infarct characterization, illustrating how infarct size, microvascular obstruction, intramyocardial hemorrhage, and peri-infarct grey zone refine risk stratification and affect clinical management.
With an educational Grant from Bayer
No CME is available for this activity. Learners may earn 1.0 hour of general education.
×
CMR in Ischaemic Heart Disease: From Viability and Infarct Characterisation to Clinical Decision-Making in Chronic Coronary Disease Course List
Login
×
Please select your language
1
English